Bill
Bill > A6293
NJ A6293
NJ A6293Permits pharmacists to provide HIV prophylaxis without individual prescription under certain conditions; requires prescription benefits coverage.
summary
Introduced
12/15/2025
12/15/2025
In Committee
12/18/2025
12/18/2025
Crossed Over
Passed
Dead
01/12/2026
01/12/2026
Introduced Session
2024-2025 Regular Session
Bill Summary
This bill permits pharmacists to dispense HIV prophylaxis without an individual prescription under certain circumstances, and requires prescription benefits coverage for prophylaxis furnished according to the bill's provisions. HIV prophylaxis includes HIV preexposure prophylaxis (PrEP) for a person who anticipates engaging in conduct that risks HIV infection, and HIV postexposure prophylaxis (PEP) for a person who may have been exposed to HIV. The bill authorizes pharmacists to dispense PrEP and PEP without an individual prescription under a standing order by the Commissioner of Health or, if the commissioner is not a physician, the Deputy Commissioner for Public Health Services. A standing order will be issued to a pharmacist, provided the pharmacist completes training provided or approved by the Department of Health, and certifies that the pharmacist will meet the bill's requirements. A patient may receive up to a 90-day supply of PrEP without a prescription in a two-year period, but must obtain a prescription to continue receiving PrEP. A pharmacist must counsel the patient on the use of PrEP, and confirm that the patient has not received PrEP without an individual prescription in the past two years. A pharmacist may dispense PEP if: the pharmacist confirms with the patient that the exposure to HIV occurred within the previous 72 hours, the patient meets the clinical criteria for PEP, and the pharmacist counsels the patient on the use of PEP. A pharmacist ordering or providing PrEP or PEP must comply with the standards of care required under Centers for Disease Control and Prevention (CDC) guidelines for a physician or other health professional ordering or providing the identical service. If the CDC guidelines are unavailable, the department will establish guidelines for pharmacists to order or provide PrEP or PEP according to the same standard of care required for a physician or other health professional providing the same service. A pharmacist who dispenses PrEP or PEP based on information provided by a patient or the patient's legal representative will not to be subject to civil liability, criminal prosecution, disciplinary action, or adverse professional licensing action for injury or damages resulting from reliance on such information. The bill requires health benefits plans that include prescription benefits, the State Health Benefits Program, the School Employees' Health Benefits Program, and the State Medicaid program to cover PrEP and PEP without prior authorization or step therapy requirements. If therapeutic equivalents to prevent HIV and AIDS are approved by the federal government, health plans may apply prior authorization or step therapy requirements to other formulations of the treatment, provided at least one formulation is covered without prior authorization or step therapy. Reimbursements to a pharmacist will be at a rate that is no less than the rate paid by the health plan to other non-physician practitioners, if the reimbursement is for a service or procedure that meets the bill's criteria.
AI Summary
This bill allows pharmacists in New Jersey to provide HIV prevention and treatment medications (known as preexposure prophylaxis or PrEP, and postexposure prophylaxis or PEP) without an individual prescription, under specific conditions. For PrEP, pharmacists can dispense up to a 90-day supply in a two-year period after completing specialized training, conducting an HIV test, counseling the patient about medication use, and verifying the patient hasn't recently received PrEP. For PEP, pharmacists can provide medication if the potential HIV exposure occurred within the past 72 hours and the patient meets clinical criteria. The bill also requires various health insurance plans, including Medicaid, State Health Benefits Program, and individual and group health plans, to cover these medications without prior authorization or step therapy requirements. Pharmacists providing these services will be reimbursed at rates comparable to other healthcare providers, and they are protected from liability when acting in good faith based on patient-provided information. The legislation aims to improve access to HIV prevention and treatment by expanding pharmacists' ability to provide these critical medications.
Committee Categories
Budget and Finance
Sponsors (3)
Last Action
Substituted by S2019 (2R) (on 12/22/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2024/A6293 |
| Fiscal Note - Fiscal Estimate 12/26/25; as introduced | https://pub.njleg.gov/Bills/2024/A6500/6293_E1.PDF |
| BillText | https://pub.njleg.gov/Bills/2024/A6500/6293_I3.HTM |
| BillText | https://pub.njleg.gov/Bills/2024/A6500/6293_I2.HTM |
| Analysis - Statement AAP 12/18/25 | https://pub.njleg.gov/Bills/2024/A6500/6293_S1.PDF |
| BillText | https://pub.njleg.gov/Bills/2024/A6500/6293_I1.HTM |
Loading...